Notable Analyst Upgrades and Downgrades for Week of October 10 2022



 

Upgrades:

 


Exane BNP Paribas upgraded shares of Kroger (NYSE:KR) from a neutral rating to an outperform rating in a report issued on Monday morning, The Fly reports.

A number of other analysts have also recently commented on KR. Credit Suisse Group dropped their price target on Kroger from $60.00 to $55.00 and set a neutral rating on the stock in a research report on Thursday, September 8th. Evercore ISI raised their price objective on shares of Kroger from $51.00 to $54.00 and gave the stock an in-line rating in a research note on Monday, September 12th. BNP Paribas raised shares of Kroger from a neutral rating to an outperform rating and set a $51.00 price target for the company in a research note on Monday. Morgan Stanley lifted their price target on shares of Kroger from $41.00 to $43.00 and gave the stock an underweight rating in a report on Monday, September 12th. Finally, Deutsche Bank Aktiengesellschaft lifted their price objective on shares of Kroger from $53.00 to $54.00 and gave the stock a hold rating in a research note on Tuesday, September 13th. Five analysts have rated the stock with a sell rating, six have assigned a hold rating, five have given a buy rating and one has given a strong buy rating to the stock. According to data from MarketBeat, Kroger currently has an average rating of Hold and a consensus target price of $52.39. Read more …

 


Guggenheim upgraded shares of Merck & Co., Inc. (NYSE:MRK) from a neutral rating to a buy rating in a research note issued to investors on Monday morning, MarketBeat reports. They currently have $104.00 price objective on the stock.

MRK has been the topic of several other reports. Cowen increased their target price on shares of Merck & Co., Inc. from $95.00 to $102.00 and gave the stock a market perform rating in a report on Monday, June 27th. Atlantic Securities lifted their price objective on shares of Merck & Co., Inc. from $105.00 to $110.00 and gave the stock an overweight rating in a research note on Wednesday, July 13th. Berenberg Bank upgraded shares of Merck & Co., Inc. from a hold rating to a buy rating and boosted their target price for the company from $95.00 to $100.00 in a research report on Wednesday, September 14th. Erste Group Bank upgraded shares of Merck & Co., Inc. from a hold rating to a buy rating in a research report on Thursday, August 25th. Finally, SVB Leerink upped their price objective on shares of Merck & Co., Inc. from $109.00 to $110.00 and gave the company an outperform rating in a research note on Friday, September 30th. Six research analysts have rated the stock with a hold rating, twelve have assigned a buy rating and two have issued a strong buy rating to the stock. Based on data from MarketBeat, the stock currently has an average rating of Moderate Buy and a consensus price target of $98.67. Read more …

 


Amgen (NASDAQ:AMGN) was upgraded by stock analysts at Morgan Stanley from an "equal weight" rating to an "overweight" rating in a research report issued to clients and investors on Tuesday, The Fly reports.

AMGN has been the topic of several other reports. TheStreet raised shares of Amgen from a "c+" rating to a "b" rating in a research report on Monday, August 15th. StockNews.com downgraded shares of Amgen from a "strong-buy" rating to a "buy" rating in a research report on Monday, August 8th. Robert W. Baird reissued an "underperform" rating and issued a $185.00 target price on shares of Amgen in a research report on Tuesday, September 13th. Royal Bank of Canada lifted their target price on shares of Amgen from $224.00 to $236.00 in a research report on Friday, August 5th. Finally, Atlantic Securities dropped their target price on shares of Amgen from $190.00 to $182.00 and set an "underweight" rating on the stock in a research report on Tuesday, August 9th. Two equities research analysts have rated the stock with a sell rating, seven have issued a hold rating and six have assigned a buy rating to the company's stock. Based on data from MarketBeat, the stock currently has an average rating of "Hold" and an average target price of $242.64. Read more …

 

 


AmerisourceBergen (NYSE:ABC) was upgraded by research analysts at Bank Of America (Bofa) to a "buy" rating in a research note issued on Tuesday, The Fly reports.

A number of other research firms have also recently weighed in on ABC. UBS Group increased their price target on AmerisourceBergen from $144.00 to $174.00 and gave the stock a "buy" rating in a report on Monday, June 13th. Argus raised their target price on AmerisourceBergen from $160.00 to $170.00 and gave the stock a "buy" rating in a research report on Wednesday, July 20th. Credit Suisse Group lowered their target price on AmerisourceBergen from $180.00 to $175.00 and set an "outperform" rating on the stock in a research note on Thursday, August 4th. Bank of America upgraded AmerisourceBergen from a "neutral" rating to a "buy" rating and lifted their price target for the company from $160.00 to $169.00 in a research note on Tuesday. Finally, Morgan Stanley boosted their price target on AmerisourceBergen from $175.00 to $176.00 and gave the stock an "equal weight" rating in a report on Monday, August 22nd. Three research analysts have rated the stock with a hold rating, eight have assigned a buy rating and one has assigned a strong buy rating to the company's stock. According to MarketBeat.com, the stock has an average rating of "Moderate Buy" and an average target price of $173.17. Read more …

 


Algonquin Power & Utilities (NYSE:AQN) was upgraded by research analysts at Credit Suisse Group from a "neutral" rating to an "outperform" rating in a research report issued to clients and investors on Tuesday, The Fly reports.

Separately, National Bank Financial upgraded Algonquin Power & Utilities from a "sector perform" rating to an "outperform" rating and dropped their price objective for the company from $16.00 to $14.25 in a report on Friday. One analyst has rated the stock with a sell rating, three have assigned a hold rating and five have issued a buy rating to the company's stock. According to MarketBeat, the company has an average rating of "Hold" and an average target price of $16.04.

Shares of AQN opened at $10.48 on Tuesday. The company has a quick ratio of 0.61, a current ratio of 0.77 and a debt-to-equity ratio of 1.06. Algonquin Power & Utilities has a 12-month low of $10.38 and a 12-month high of $16.01. The firm has a market capitalization of $7.06 billion, a PE ratio of 34.93, a price-to-earnings-growth ratio of 1.92 and a beta of 0.58. The stock's fifty day simple moving average is $13.37 and its 200-day simple moving average is $13.98. Read more …

 


Allstate (NYSE:ALL) was upgraded by Keefe, Bruyette & Woods from a “market perform” rating to an “outperform” rating in a report issued on Tuesday, Marketbeat Ratings reports. The firm currently has a $158.00 price target on the insurance provider’s stock, up from their prior price target of $136.00. Keefe, Bruyette & Woods’ price target suggests a potential upside of 20.49% from the stock’s previous close.

Other equities analysts also recently issued research reports about the company. Wells Fargo & Company reduced their price target on Allstate from $116.00 to $110.00 and set an “underweight” rating for the company in a research report on Thursday, July 21st. Raymond James reduced their price objective on Allstate from $165.00 to $155.00 in a research note on Thursday, July 21st. Barclays cut their price objective on Allstate from $123.00 to $120.00 and set an “equal weight” rating on the stock in a research report on Monday, August 8th. TheStreet upgraded Allstate from a “c+” rating to a “b-” rating in a research note on Friday, September 16th. Finally, Evercore ISI upped their price objective on Allstate to $126.00 in a report on Tuesday, August 9th. One investment analyst has rated the stock with a sell rating, five have assigned a hold rating, seven have given a buy rating and one has assigned a strong buy rating to the company’s stock. Based on data from MarketBeat, Allstate presently has an average rating of “Moderate Buy” and a consensus price target of $143.38. Read more …

 

 


CME Group (NASDAQ:CME) was upgraded by stock analysts at Deutsche Bank Aktiengesellschaft from a “hold” rating to a “buy” rating in a report issued on Wednesday, Marketbeat reports. The firm currently has a $200.00 target price on the financial services provider’s stock, down from their previous target price of $212.00. Deutsche Bank Aktiengesellschaft’s price target would suggest a potential upside of 14.65% from the stock’s previous close.

Several other equities research analysts have also recently issued reports on the company. Morgan Stanley decreased their price objective on CME Group from $242.00 to $226.00 and set an “equal weight” rating on the stock in a report on Thursday, July 28th. Rosenblatt Securities decreased their price objective on CME Group from $171.00 to $161.00 and set a “sell” rating on the stock in a report on Wednesday, October 5th. Credit Suisse Group decreased their price objective on CME Group from $216.00 to $210.00 and set a “neutral” rating on the stock in a report on Tuesday, September 6th. StockNews.com started coverage on CME Group in a report on Wednesday. They set a “hold” rating on the stock. Finally, Raymond James cut CME Group from an “outperform” rating to a “market perform” rating in a report on Monday, August 15th. Two investment analysts have rated the stock with a sell rating, seven have assigned a hold rating and six have issued a buy rating to the company. Based on data from MarketBeat.com, the company presently has an average rating of “Hold” and an average price target of $224.07. Read more …

 


Sonoco Products (NYSE:SON) was upgraded by equities research analysts at Bank of America from an "underperform" rating to a "buy" rating in a note issued to investors on Thursday, The Fly reports.

Other research analysts have also issued reports about the stock. StockNews.com began coverage on shares of Sonoco Products in a report on Wednesday. They issued a "hold" rating for the company. TheStreet raised shares of Sonoco Products from a "c+" rating to a "b-" rating in a report on Thursday, July 21st. Wells Fargo & Company lifted their price objective on shares of Sonoco Products to $67.00 in a research report on Friday, July 22nd. Finally, Citigroup cut their price objective on shares of Sonoco Products from $73.00 to $72.00 and set a "buy" rating on the stock in a research report on Tuesday. Five investment analysts have rated the stock with a hold rating and four have issued a buy rating to the company's stock. According to data from MarketBeat.com, the company currently has an average rating of "Hold" and a consensus price target of $65.43. Read more …

 


Air Products and Chemicals (NYSE:APD) was upgraded by investment analysts at Seaport Res Ptn from a "neutral" rating to a "buy" rating in a note issued to investors on Thursday, PriceTargets.com reports. Seaport Res Ptn also issued estimates for Air Products and Chemicals' Q4 2022 earnings at $2.78 EPS, Q1 2023 earnings at $2.70 EPS, Q2 2023 earnings at $2.64 EPS, Q3 2023 earnings at $2.81 EPS, Q4 2023 earnings at $3.05 EPS, FY2023 earnings at $11.19 EPS and FY2024 earnings at $12.30 EPS.

Several other research firms have also recently commented on APD. Jefferies Financial Group lowered their price target on shares of Air Products and Chemicals from $270.00 to $257.00 in a report on Thursday, June 16th. Berenberg Bank lowered their price target on shares of Air Products and Chemicals from $290.00 to $260.00 and set a "hold" rating for the company in a report on Wednesday. StockNews.com initiated coverage on shares of Air Products and Chemicals in a report on Wednesday. They set a "hold" rating for the company. BMO Capital Markets upgraded shares of Air Products and Chemicals from a "market perform" rating to an "outperform" rating and boosted their price objective for the stock from $283.00 to $321.00 in a research report on Monday, August 15th. Finally, Wells Fargo & Company reduced their price objective on shares of Air Products and Chemicals from $255.00 to $243.00 and set an "equal weight" rating for the company in a research report on Monday, July 18th. Six research analysts have rated the stock with a hold rating and ten have given a buy rating to the company. Based on data from MarketBeat.com, the company has a consensus rating of "Moderate Buy" and an average price target of $289.72. Read more …

 

 


Ecolab (NYSE:ECL) was upgraded by research analysts at Seaport Res Ptn from a "neutral" rating to a "buy" rating in a research note issued to investors on Thursday, PriceTargets.com reports.

ECL has been the topic of a number of other research reports. Royal Bank of Canada cut their price target on shares of Ecolab from $225.00 to $190.00 in a research note on Thursday, July 14th. Deutsche Bank Aktiengesellschaft decreased their price objective on shares of Ecolab from $195.00 to $180.00 in a report on Wednesday, July 27th. Northcoast Research raised shares of Ecolab from a "neutral" rating to a "buy" rating and set a $188.00 price target on the stock in a research note on Tuesday, September 6th. StockNews.com began coverage on shares of Ecolab in a research note on Wednesday. They issued a "hold" rating on the stock. Finally, Morgan Stanley reduced their target price on shares of Ecolab from $200.00 to $181.00 and set an "equal weight" rating on the stock in a research note on Monday, June 27th. Eight analysts have rated the stock with a hold rating and eleven have assigned a buy rating to the stock. According to data from MarketBeat, the stock currently has a consensus rating of "Moderate Buy" and a consensus target price of $191.35. Read more …

 


Sherwin-Williams (NYSE:SHW) was upgraded by Seaport Res Ptn from a "neutral" rating to a "buy" rating in a research note issued on Thursday, PriceTargets.com reports.

Several other equities research analysts have also recently commented on the company. Bank of America cut their price target on Sherwin-Williams from $280.00 to $257.00 in a report on Tuesday. KeyCorp cut their price target on Sherwin-Williams from $335.00 to $290.00 and set an "overweight" rating for the company in a report on Thursday, July 28th. Wells Fargo & Company cut their price target on Sherwin-Williams from $285.00 to $270.00 and set an "equal weight" rating for the company in a report on Monday, July 18th. Northcoast Research raised Sherwin-Williams from a "neutral" rating to a "buy" rating and set a $300.00 price target for the company in a report on Tuesday, July 12th. Finally, Citigroup cut their price target on Sherwin-Williams from $248.00 to $215.00 in a report on Tuesday, October 4th. One equities research analyst has rated the stock with a sell rating, seven have issued a hold rating and ten have issued a buy rating to the stock. Based on data from MarketBeat.com, the stock presently has an average rating of "Moderate Buy" and a consensus price target of $296.26. Read more …

 


CSX (NASDAQ:CSX) was upgraded by equities research analysts at Vertical Research from a "hold" rating to a "buy" rating in a report released on Friday, The Fly reports.

A number of other analysts also recently issued reports on CSX. Barclays lowered their price objective on shares of CSX from $40.00 to $35.00 and set an "overweight" rating on the stock in a report on Friday, September 30th. The Goldman Sachs Group reduced their price objective on shares of CSX from $37.00 to $33.00 and set a "buy" rating for the company in a research note on Monday. Robert W. Baird dropped their target price on CSX to $34.00 in a report on Thursday. Morgan Stanley reduced their price target on CSX from $25.00 to $23.00 and set an "underweight" rating for the company in a research report on Monday, October 3rd. Finally, Susquehanna lowered CSX from a "positive" rating to a "neutral" rating and lowered their price target for the stock from $35.00 to $29.00 in a research report on Wednesday, September 28th. One research analyst has rated the stock with a sell rating, eleven have given a hold rating and thirteen have issued a buy rating to the company's stock. According to data from MarketBeat, the company has a consensus rating of "Hold" and an average price target of $34.42. Read more …

 

 


C.H. Robinson Worldwide (NASDAQ:CHRW) was upgraded by analysts at Vertical Research from a "sell" rating to a "hold" rating in a note issued to investors on Friday, The Fly reports.

CHRW has been the subject of several other research reports. Morgan Stanley raised their target price on C.H. Robinson Worldwide from $66.00 to $67.00 and gave the stock an "underweight" rating in a research note on Monday, October 3rd. Credit Suisse Group decreased their price target on shares of C.H. Robinson Worldwide from $118.00 to $98.00 in a research note on Tuesday. Citigroup downgraded C.H. Robinson Worldwide from a "buy" rating to a "neutral" rating and dropped their price target for the stock from $123.00 to $107.00 in a research note on Friday, October 7th. Wolfe Research downgraded C.H. Robinson Worldwide from an "outperform" rating to a "peer perform" rating in a report on Tuesday, July 12th. Finally, StockNews.com assumed coverage on C.H. Robinson Worldwide in a report on Wednesday. They issued a "hold" rating on the stock. Three equities research analysts have rated the stock with a sell rating, nine have given a hold rating and seven have given a buy rating to the company's stock. Based on data from MarketBeat.com, the stock has an average rating of "Hold" and a consensus price target of $109.52. Read more …

 

 

Downgrades:

 


The Goldman Sachs Group downgraded shares of Procter & Gamble (NYSE:PG) from a buy rating to a neutral rating in a research note released on Sunday, The Fly reports.

Several other analysts have also issued reports on the stock. Wells Fargo & Company reduced their target price on shares of Procter & Gamble from $160.00 to $150.00 and set an overweight rating for the company in a research note on Monday, October 3rd. Evercore ISI set a $170.00 target price on shares of Procter & Gamble in a research note on Monday, June 20th. Barclays reduced their target price on shares of Procter & Gamble from $157.00 to $154.00 and set an overweight rating for the company in a research note on Tuesday, August 2nd. JPMorgan Chase & Co. reduced their price target on shares of Procter & Gamble from $165.00 to $156.00 in a research report on Thursday, July 21st. Finally, Deutsche Bank Aktiengesellschaft reduced their price target on shares of Procter & Gamble from $171.00 to $157.00 and set a buy rating for the company in a research report on Tuesday, June 21st. Six analysts have rated the stock with a hold rating and six have given a buy rating to the company’s stock. According to MarketBeat.com, the company presently has an average rating of Moderate Buy and an average target price of $161.00. Read more …

 


Bristol-Myers Squibb (NYSE:BMY) was downgraded by stock analysts at Guggenheim from a "buy" rating to a "neutral" rating in a research report issued to clients and investors on Monday, The Fly reports.

Several other research analysts have also recently commented on BMY. JPMorgan Chase & Co. raised their target price on shares of Bristol-Myers Squibb from $80.00 to $85.00 in a report on Thursday, July 28th. UBS Group raised their target price on shares of Bristol-Myers Squibb to $73.00 and gave the stock an "outperform" rating in a report on Wednesday, July 27th. Atlantic Securities raised their target price on shares of Bristol-Myers Squibb from $83.00 to $87.00 and gave the stock an "overweight" rating in a report on Monday, September 12th. BMO Capital Markets raised their target price on shares of Bristol-Myers Squibb from $92.00 to $94.00 and gave the stock an "outperform" rating in a report on Monday, September 12th. Finally, The Goldman Sachs Group reaffirmed a "buy" rating and set a $85.00 target price on shares of Bristol-Myers Squibb in a report on Tuesday, September 27th. One analyst has rated the stock with a sell rating, six have assigned a hold rating, six have assigned a buy rating and one has given a strong buy rating to the stock. Based on data from MarketBeat, Bristol-Myers Squibb has a consensus rating of "Moderate Buy" and a consensus price target of $77.29. Read more …

 

 


Kilroy Realty (NYSE:KRC) was downgraded by Robert W. Baird from an "outperform" rating to a "neutral" rating in a note issued to investors on Monday, The Fly reports. They currently have a $49.00 target price on the real estate investment trust's stock. Robert W. Baird's price target would indicate a potential upside of 20.39% from the company's previous close.

Several other research firms have also recently commented on KRC. Credit Suisse Group initiated coverage on Kilroy Realty in a research report on Wednesday, June 22nd. They set an "underperform" rating and a $48.00 target price for the company. Mizuho reduced their target price on Kilroy Realty from $77.00 to $60.00 and set a "buy" rating for the company in a research report on Wednesday, July 6th. Jefferies Financial Group reduced their target price on Kilroy Realty from $76.00 to $58.00 and set a "buy" rating for the company in a research report on Thursday, June 30th. Wells Fargo & Company cut their price objective on Kilroy Realty from $60.00 to $57.00 and set an "overweight" rating for the company in a report on Tuesday, August 30th. Finally, Deutsche Bank Aktiengesellschaft cut their price objective on Kilroy Realty from $75.00 to $60.00 in a report on Wednesday, July 20th. One investment analyst has rated the stock with a sell rating, six have given a hold rating and seven have given a buy rating to the stock. Based on data from MarketBeat, the stock currently has an average rating of "Hold" and a consensus price target of $63.92. Read more …

 


BlackRock (NYSE:BLK) was downgraded by research analysts at UBS Group from a "buy" rating to a "neutral" rating in a research report issued on Tuesday, The Fly reports.

Other equities analysts have also recently issued reports about the stock. Keefe, Bruyette & Woods decreased their price target on shares of BlackRock from $719.00 to $675.00 and set a "market perform" rating for the company in a research report on Tuesday, June 28th. Morgan Stanley dropped their price target on shares of BlackRock from $773.00 to $754.00 and set an "overweight" rating on the stock in a research report on Monday, October 3rd. The Goldman Sachs Group decreased their price objective on shares of BlackRock from $830.00 to $710.00 and set a "buy" rating for the company in a report on Wednesday, June 29th. StockNews.com upgraded shares of BlackRock from a "sell" rating to a "hold" rating in a research note on Tuesday, August 16th. Finally, Deutsche Bank Aktiengesellschaft boosted their price objective on shares of BlackRock from $720.00 to $860.00 and gave the company a "buy" rating in a research note on Friday, August 12th. Six research analysts have rated the stock with a hold rating and eight have given a buy rating to the company. Based on data from MarketBeat, BlackRock has a consensus rating of "Moderate Buy" and an average target price of $803.00. Read more …

 


Albemarle (NYSE:ALB) was downgraded by stock analysts at Berenberg Bank from a "buy" rating to a "hold" rating in a research report issued on Thursday, The Fly reports.

A number of other research firms have also issued reports on ALB. Oppenheimer increased their price target on shares of Albemarle from $368.00 to $440.00 and gave the stock an "outperform" rating in a research report on Monday, August 8th. Jefferies Financial Group reaffirmed a "buy" rating and set a $350.00 price objective on shares of Albemarle in a research report on Friday, September 30th. Royal Bank of Canada raised their price objective on shares of Albemarle from $357.00 to $371.00 and gave the company an "outperform" rating in a research report on Thursday, September 8th. UBS Group raised their price objective on shares of Albemarle from $218.00 to $265.00 and gave the company a "neutral" rating in a research report on Thursday, August 4th. Finally, Deutsche Bank Aktiengesellschaft raised their price objective on shares of Albemarle from $270.00 to $305.00 and gave the company a "buy" rating in a research report on Tuesday, October 4th. Two investment analysts have rated the stock with a sell rating, six have issued a hold rating and eight have given a buy rating to the company. According to data from MarketBeat.com, the company has a consensus rating of "Hold" and a consensus target price of $295.79. Read more …

 

 


Black Hills (NYSE:BKH) was downgraded by equities research analysts at Bank of America from a "buy" rating to a "neutral" rating in a research note issued on Thursday, Marketbeat.com reports. They currently have a $66.00 price objective on the utilities provider's stock, down from their prior price objective of $87.00. Bank of America's price target points to a potential upside of 5.36% from the company's current price.

Several other brokerages have also recently issued reports on BKH. StockNews.com began coverage on shares of Black Hills in a research report on Wednesday. They set a "hold" rating on the stock. Siebert Williams Shank raised their target price on shares of Black Hills to $84.00 in a report on Tuesday, September 13th.

Shares of BKH opened at $62.64 on Thursday. The stock has a market capitalization of $4.06 billion, a PE ratio of 15.09, a P/E/G ratio of 2.56 and a beta of 0.53. Black Hills has a 1 year low of $62.60 and a 1 year high of $80.95. The company has a debt-to-equity ratio of 1.38, a quick ratio of 0.77 and a current ratio of 0.97. The company's 50-day simple moving average is $74.51 and its 200-day simple moving average is $74.58. Read more …

 


Stanley Black & Decker (NYSE:SWK) was downgraded by research analysts at Credit Suisse Group from an "outperform" rating to a "neutral" rating in a research report issued on Friday, The Fly reports. They presently have a $79.00 price objective on the industrial products company's stock, down from their previous price objective of $125.00. Credit Suisse Group's price target would indicate a potential upside of 2.54% from the stock's current price.

A number of other research firms have also weighed in on SWK. Mizuho dropped their price objective on Stanley Black & Decker from $145.00 to $100.00 and set a "neutral" rating for the company in a research note on Monday, July 18th. StockNews.com initiated coverage on Stanley Black & Decker in a research note on Wednesday. They issued a "sell" rating for the company. Wells Fargo & Company lowered Stanley Black & Decker to an "equal weight" rating in a research note on Tuesday, August 9th. Wolfe Research downgraded Stanley Black & Decker from an "outperform" rating to a "market perform" rating in a research report on Friday, July 29th. Finally, Barclays decreased their target price on Stanley Black & Decker from $120.00 to $118.00 and set an "overweight" rating on the stock in a research report on Monday, October 3rd. Three investment analysts have rated the stock with a sell rating, nine have assigned a hold rating and one has assigned a buy rating to the company's stock. According to MarketBeat.com, Stanley Black & Decker presently has a consensus rating of "Hold" and an average target price of $103.25. Read more …

 


Northrop Grumman (NYSE:NOC) was downgraded by equities research analysts at JPMorgan Chase & Co. from an "overweight" rating to a "neutral" rating in a research note issued on Friday, The Fly reports. They presently have a $490.00 price objective on the aerospace company's stock. JPMorgan Chase & Co.'s target price indicates a potential downside of 2.28% from the stock's current price.

Other equities research analysts have also issued reports about the stock. Credit Suisse Group assumed coverage on shares of Northrop Grumman in a research note on Tuesday. They set an "outperform" rating and a $560.00 price target on the stock. Wells Fargo & Company lifted their price target on shares of Northrop Grumman from $455.00 to $516.00 and gave the stock an "equal weight" rating in a research note on Wednesday, September 28th. Cowen set a $510.00 price target on shares of Northrop Grumman in a research note on Tuesday, July 19th. Wolfe Research began coverage on shares of Northrop Grumman in a research note on Monday. They set an "outperform" rating and a $565.00 price target on the stock. Finally, StockNews.com began coverage on shares of Northrop Grumman in a research note on Wednesday. They issued a "buy" rating on the stock. Six analysts have rated the stock with a hold rating and eight have assigned a buy rating to the stock. According to MarketBeat.com, the company has a consensus rating of "Moderate Buy" and an average target price of $517.31. Read more …


 


Comments